Safty evaluation, migration and distribution of human bone marrow derived-mesenchymal stem cells in the cns of young macaca fascicularis
CSTR:
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [17]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    Objective To evalutate the safty of hBMSCs transpalntation and to observe their migration and distribution in the brain of young macaca fascicularis. To establish a new technology platform and theoretical basis for the treatment of central nervous system diseases in children.Methods Labelled hBMSCs were transplanted into the striatum of young macaca fascicularis. Brain sections were examined to evalutate the inflammatory reaction and immunological rejection of local injection sites by HE observation and immunohistochemical staining. Migration and distribution of transplanted-hBMSCs was observed by real-time fluorescence quantitative PCR of male DNA and fluorescence microscope.Results The results showed that the direct intracerebral injection of hBMSCs did not cause systemic symptoms in animals. There is no inflammatory reaction and immunological rejection was detected, and degeneration and necrosis of neural cells and proliferation of glial cells were absent in the local injection sites. The transplanted hBMSCs survived, and migrated into the brain after 4 weeks transplantation. Its migration and distribution have certain regularity and were overlapping between transplant recipients. In addtion, hBMSCs tended to extend rostrally into the forebrain and showed preference of migrating toward the blood vessels and below the ependyma.Conculsions Intracerebral transplantation of hBMSCs is safe. And hBMSCs can survive and migrate into the brain.

    Reference
    [1] Castillo-Melendez M, Yawno T, Jenkin G, et al. Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells[J]. Front Neurosci, 2013,7:194.
    [2] Dailey T, Tajiri N, Kaneko Y, et al. Regeneration of neuronal cells following cerebral injury[J]. Front Neurol Neurosci, 2013,32:54-61.
    [3] Hsu YC, Chen SL, Wang DY, et al. Stem cell-based therapy in neural repair[J]. Biomed J, 2013,36(3):98-105.
    [4] van Velthoven CT, Sheldon RA, Kavelaars A, et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke[J]. Stroke, 2013,44(5):1426-1432.
    [5] van Velthoven CT, Kavelaars A, Heijnen CJ. Mesenchymal stem cells as a treatment for neonatal ischemic brain damage[J]. Pediatr Res, 2012,71:474-481.
    [6] Okuma Y,Wang F,Toyoshima A,et al.Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after traumatic brain injury[J]. Neurosci Lett, 2013,554:156-161.
    [7] Liu L, Eckert MA, Riazifar H, et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier?[J]. Stem Cells Int, 2013,2013:435093.
    [8] Forostyak S, Jendelova P, Sykova E. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications[J]. Biochimie, 2013,95(12):2257-2270.
    [9] Li J, Zhu H, Liu Y, et al. Human mesenchymal stem cell transplantation protects against cerebral ischemic injury and upregulates interleukin-10 expression in Macaca fascicularis[J]. Brain Res, 2010,1334:65-72.
    [10] Isakova IA, Baker K, Dufour J, et al. Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques[J]. Mol Ther, 2006,13(6):1173-1184.
    [11] Yun HM, Kim HS, Park KR, et al. Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ1-42-infused mouse model of Alzheimer's disease[J]. Cell Death Dis, 2013,4:e958.
    [12] Kim KS, Kim HS, Park JM, et al. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model[J]. Neurobiol Aging, 2013,34(10):2408-2420.
    [13] Glavaski-Joksimovic A, Bohn MC. Mesenchymal stem cells and neuroregeneration in Parkinson's disease[J]. Exp Neurol, 2013,247:25-38.
    [14] Kopen GC, Prockop DJ, Phinney, DG. Marrow stromal cells migrate throughout forebrain and cerebellum and they differentiate into astrocytes after injection into neonatal mouse brains[J]. Proc Natl Acad Sci USA, 1999,96(19): 10711-10716.
    [15] McBride C, Gaupp D, Phinney DG. Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR[J]. Cytotherapy, 2003,5(1):7-18.
    [16] Muñoz-Elias G, Marcus AJ, Coyne TM, et al. Adult Bone Marrow Stromal Cells in the Embryonic Brain: Engraftment, Migration, Differentiation, and Long-TermSurvival[J]. The Journal of Neuroscience, 2004,24(19):4585-4595.
    [17] Bae JS, Furuya S, Ahn SJ, et al. Neuroglial activation in Niemann-Pick type C mice is suppressed by intracerebral transplantation of bone marrow derived mesenchymal stem cells[J]. Neurosci Lett, 2005,381(3):234-236.
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Revised:March 08,2016
  • Online: September 22,2016
Article QR Code